Tag: trial feasibility

Overcoming Randomization Limitations in Ultra-Rare Disease Studies

August 22, 2025

Overcoming Randomization Limitations in Ultra-Rare Disease Studies Innovative Strategies to Address Randomization Challenges in Ultra-Rare Disease Trials Understanding the Randomization Barrier in Ultra-Rare Disease Research Randomization is a fundamental principle in clinical trial design, intended to reduce bias and ensure balanced comparison groups. However, in the context of ultra-rare diseases—conditions affecting fewer than one in…

Rare and Orphan Disease Trials, Trial Design & Methodology

AI-Powered Trial Simulation Models for Small Populations

August 21, 2025

digi

AI-Powered Trial Simulation Models for Small Populations How AI-Powered Trial Simulations Transform Small-Population Rare Disease Research The Role of Simulation in Rare Disease Clinical Development Rare disease clinical trials often face critical limitations—small patient populations, high variability in disease progression, and ethical constraints on placebo use. Traditional statistical models frequently fall short, making it difficult…

Data & Technology, Rare and Orphan Disease Trials

Using Genomic Databases for Rare Disease Trial Recruitment

August 20, 2025

digi

Using Genomic Databases for Rare Disease Trial Recruitment Leveraging Genomic Databases to Enhance Recruitment in Rare Disease Clinical Trials The Importance of Genomic Data in Rare Disease Research Rare disease trials face a unique bottleneck—finding eligible participants within very small patient populations. Many rare diseases are defined by genetic mutations, and access to genomic databases…

Data & Technology, Rare and Orphan Disease Trials

How Drug Repurposing Transformed a Rare Disease Treatment Landscape

August 18, 2025

digi

How Drug Repurposing Transformed a Rare Disease Treatment Landscape Revolutionizing Rare Disease Care Through Drug Repurposing Introduction: The Value of Repurposing in Rare Diseases Developing new medicines for rare diseases has historically faced significant challenges: small patient populations, high research costs, and uncertain returns on investment. Drug repurposing—also called repositioning—has emerged as a pragmatic solution,…

Case Studies & Breakthroughs, Rare and Orphan Disease Trials

Lessons from First-in-Human Trials for Ultra-Rare Disorders

August 17, 2025

digi

Lessons from First-in-Human Trials for Ultra-Rare Disorders Key Learnings from First-in-Human Trials in Ultra-Rare Disorders Introduction: The Complexity of First-in-Human Trials First-in-human (FIH) trials mark the critical juncture where laboratory discoveries transition into patient care. For ultra-rare disorders—conditions affecting fewer than 1 in 50,000 people—these trials are uniquely complex. Unlike common diseases where large populations…

Case Studies & Breakthroughs, Rare and Orphan Disease Trials

Patient-Led Clinical Research in Rare Diseases: Success Models

August 17, 2025

digi

Patient-Led Clinical Research in Rare Diseases: Success Models Success Models of Patient-Led Clinical Research in Rare Diseases Introduction: Patients as Catalysts for Rare Disease Research In the traditional research paradigm, patients are often passive participants, enrolled in studies designed and managed by pharmaceutical sponsors or academic investigators. Rare disease research challenges this model. With limited…

Case Studies & Breakthroughs, Rare and Orphan Disease Trials

Case Study: Overcoming Recruitment Barriers in Rare Disease Trials

August 12, 2025

digi

Case Study: Overcoming Recruitment Barriers in Rare Disease Trials Lessons from Overcoming Recruitment Barriers in Rare Disease Clinical Trials Introduction: Why Recruitment Is the Greatest Barrier in Rare Disease Research Recruitment remains the single most critical challenge in rare disease clinical trials. With patient populations often numbering in the hundreds—or even dozens—globally, traditional recruitment approaches…

Case Studies & Breakthroughs, Rare and Orphan Disease Trials

Why Adaptive Designs Fit Rare Disease Trials

August 7, 2025

digi

Why Adaptive Designs Fit Rare Disease Trials The Strategic Role of Adaptive Designs in Rare Disease Clinical Trials Introduction: The Trial Design Challenge in Rare Diseases Rare disease clinical trials are often hindered by challenges like small sample sizes, heterogeneous populations, ethical constraints, and limited natural history data. Traditional randomized controlled trials (RCTs) may not…

Adaptive Trial Designs, Rare and Orphan Disease Trials